AbCellera Biologics (ABCL) EBT Margin (2020 - 2026)
AbCellera Biologics (ABCL) posted EBT Margin of 595.75% for Q1 2026, down 1270.4% on a QoQ basis from 43.47% in Q4 2025, and up 65534.0% year-over-year from N/an in Q1 2025.
AbCellera Biologics (ABCL) EBT Margin (2020 - 2026) Analysis & Trends
AbCellera Biologics' EBT Margin history runs 7 years deep, the most recent figure standing at 595.75% for Q1 2026.
- Quarterly EBT Margin rose 65534.0% year-over-year to 595.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 219.86% (up 69137.0% YoY) and the FY2025 annual result came in at 236.39%, up 45863.0% from the prior year.
- EBT Margin was 595.75% for Q1 2026 at AbCellera Biologics, down from 43.47% in the prior quarter.
- Across five years, EBT Margin topped out at 72.91% in Q1 2022 and bottomed at 1251.1% in Q1 2025.
- A 5-year average of 458.1% and a median of 429.45% in 2024 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 88383 bps in 2025, while the deepest fall reached 82165 bps in 2025.
- AbCellera Biologics' EBT Margin stood at 145.8% in 2022, then sank by 263 bps to 529.49% in 2023, then tumbled by 75 bps to 927.31% in 2024, then soared by 95 bps to 43.47% in 2025, then tumbled by 1270 bps to 595.75% in 2026.
- Business Quant data shows ABCL's EBT Margin at 595.75% in Q1 2026, 43.47% in Q4 2025, and 767.93% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -595.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -595.75% |
| Dec 31, 2025 | -43.47% |
| Sep 30, 2025 | -767.93% |
| Jun 30, 2025 | -212.74% |
| Mar 31, 2025 | -1,251.10% |
| Dec 31, 2024 | -927.31% |
| Sep 30, 2024 | -962.53% |
| Jun 30, 2024 | -658.02% |
| Mar 31, 2024 | -429.45% |
| Dec 31, 2023 | -529.49% |
| Sep 30, 2023 | -595.18% |
| Jun 30, 2023 | -377.92% |
| Mar 31, 2023 | -394.91% |
| Dec 31, 2022 | -145.80% |
| Sep 30, 2022 | 45.95% |
| Jun 30, 2022 | -15.00% |
| Mar 31, 2022 | 72.91% |
| Dec 31, 2021 | 60.80% |
| Sep 30, 2021 | -453.38% |
| Jun 30, 2021 | -7.50% |